4.5 Article

HIV-2/SIV viral protein X counteracts HUSH repressor complex

期刊

NATURE MICROBIOLOGY
卷 3, 期 8, 页码 891-897

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/s41564-018-0179-6

关键词

-

资金

  1. Agence Nationale de la Recherche sur le SIDA et les hepatites virales (ANRS)
  2. SIDACTION
  3. Fondation de France
  4. Fondation pour la Recherche Medicale (FRM) [DEQ20140329528]
  5. French government
  6. amfAR (Mathilde Krim Phase II Fellowship) [109140-58-RKHF]
  7. Fondation pour la Recherche Medicale (FRM 'Projet Innovant') [ING20160435028]
  8. FINOVI ('Recently Settled Scientist' grant)
  9. ANRS [ECTZ19143]
  10. ANR LABEX ECOFECT (Universite de Lyon, within the programme 'Investissements d'Avenir' [ANR-11-LABX-0048, ANR-11-IDEX-0007]
  11. CNRS

向作者/读者索取更多资源

To evade host immune defences, human immunodeficiency viruses 1 and 2 (HIV-1 and HIV-2) have evolved auxiliary proteins that target cell restriction factors. Viral protein X (Vpx) from the HIV-2/SIVsmm lineage enhances viral infection by antagonizing SAMHD1 (refs(1,2)), but this antagonism is not sufficient to explain all Vpx phenotypes. Here, through a proteomic screen, we identified another Vpx target-HUSH (TASOR, MPP8 and periphilin)-a complex involved in position-effect variegation(3). HUSH downregulation by Vpx is observed in primary cells and HIV-2-infected cells. Vpx binds HUSH and induces its proteasomal degradation through the recruitment of the DCAF1 ubiquitin ligase adaptor, independently from SAMHD1 antagonism. As a consequence, Vpx is able to reactivate HIV latent proviruses, unlike Vpx mutants, which are unable to induce HUSH degradation. Although antagonism of human HUSH is not conserved among all lentiviral lineages including HIV-1, it is a feature of viral protein R (Vpr) from simian immunodeficiency viruses (SIVs) of African green monkeys and from the divergent SIV of l'Hoest's monkey, arguing in favour of an ancient lentiviral species-specific vpx/vpr gene function. Altogether, our results suggest the HUSH complex as a restriction factor, active in primary CD4(+) T cells and counteracted by Vpx, therefore providing a molecular link between intrinsic immunity and epigenetic control.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据